In 1998, Fred Hutch’s Cancer Biology Program merged with the Division of Molecular Medicine and an initiative in genetics/genomics to create the Human Biology Division. Since then, we’ve performed ongoing laboratory-based and computational research, driving the translation of research into life-saving treatments.
Researchers work across divisions to increase our knowledge base of genetic profiles and epidemiology. Our studies focus on breast, cervical, ovarian, prostate and esophageal cancers, as well as non-solid tumors and infectious diseases that influence cancers. The more we learn about the relationships between human biology and these diseases, the better we’ll be able to prevent, diagnose and treat cancer.
Director, Eric Holland, M.D., Ph.D.
Dr. Holland became director of the Human Biology Division in 2013. He is committed to keeping the scientific focus of the division diverse while growing solid tumor research at the center. As a practicing neurosurgeon conducting research in molecular biology and genetics, Dr. Holland is at the forefront of translating laboratory advances into advanced molecular therapeutics.
Associate Director, Adam Geballe, M.D.
Dr. Geballe has a long history with the Human Biology Division at Fred Hutch and continues to support its scientists as associate director. Dr. Geballe’s current research focuses on the functions and mechanisms of genes encoded by large DNA viruses and how they promote viral growth by blocking host cell defenses.
Senior Operations Director, Angie Schroeder
As Senior Operations Director for Human Biology, Angie Schroeder oversees day-to-day and long-range strategic planning, as well as all operational, financial and human resources for the division.
The Human Biology Retreat hosts a two-day retreate each year event this year for faculty members share their research interests and accomplishments. View the 2019 Retreat Brochure
Collaboration is at the Foundation of Our Research
Our best work can’t be done in a vacuum, and the more opportunities we have to share our science, the greater the possibility we have for live-saving discoveries. Through groups like our Integrated Research Centers (IRCs) and the Solid Tumor Translational Research (STTR), Fred Hutch supports collaboration at a structural level.
The Immunotherapy Integrated Research Center (IIRC) creates a partnership across the Hutch in cell therapy, transplant immunology, tumor microenvironment, immune checkpoint regulation, immunogenomics, therapeutic vaccines and more, to develop the next generation of immune-based lifesaving therapies.
The Pathogen-Associated Malignancies Integrated Research Center (PAM IRC) combines research in infectious diseases, host-pathogen interactions, cancer biology, immunology, global oncology and immunotherapy to understand, treat and prevent cancers linked to infectious agents.
The Translational Data Science Integrated Research Center (TDS IRC) works in tandem with the Hutch Data Commonwealth to conduct the research needed to grow the center’s data science infrastructure, support large-scale biological experiments, and create effective computational methods.
Fred Hutch, UW Medicine and Seattle Cancer Care Alliance researchers and physicians focused on bridging laboratory sciences and patient care formed a network to increase our understanding of solid tumors. The STTR provides a framework for transforming research into patient care.